News
Important Only
MIDEAST STOCKS-Saudi bourse falls on Trump tariff plan; Qatar gains
By Ateeq Shariff Feb 2 (Reuters) - Saudi Arabia's stock market ended lower on Sunday after U.S. President Donald Trump announced tariffs on Canada, Mexico and China, while the Qatari index gained ahead of several corporate earnings statements.The U.S. tariffs may impact the Gulf region's ...Reuters
Sun, Feb 2
1 Top Risk the Smartest Investors Know About SoFi Stock
SoFi Technologies (NASDAQ: SOFI) has been kind to its investors. In the past 12 months, shares have more than doubled. The fintech stock still trades 38% below its peak from February 2021. And when you look at the latest financial results, there are reasons investors should be optimistic.Where to in...The Motley Fool
Sun, Feb 2
3 Smart EV Stocks to Buy With $1,000 Right Now
Many electric car stocks had a difficult 2024. Industrywide growth fell below initial expectations, with some EV stocks falling in value by 50% or more. But the long-term growth trajectory of EV demand remains intact.So if you have $1,000 with you that you won't require for essential spending, and a...The Motley Fool
Sun, Feb 2
AST SpaceMobile Investors: Prepare to Be Diluted
I hate to say I told you so (but I did). And just as I forewarned back in September, AST SpaceMobile (NASDAQ: ASTS) stock has decided to dilute its investors.Again.Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. See the 10 s...The Motley Fool
Sun, Feb 2
Vertex Pharmaceuticals Just Won a Huge FDA Approval. Is the Biotech Stock a No-Brainer Buy?
Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up to Alyftrek in treating cystic fibrosis (CF). Last Thursday, the agency approved Vertex's Journavx in treating adults with modera...The Motley Fool
Sun, Feb 2
Carnival Stock Is Up 75%. Is It Time to Sell?
Carnival (NYSE: CCL) (NYSE: CUK) finished 2024 in a solid financial position. It reported record revenue and returned to profitability, and the stock responded by climbing 75% over the last 12 months. Investors who bought the stock a year ago might be tempted to take profits, but there's tremendous ...The Motley Fool
Sun, Feb 2
With Zepbound Not Matching Expectations, Should Investors Give Up on Eli Lilly?
Over the past six months, Eli Lilly (NYSE: LLY) has underperformed broader equities. While that's not much of an issue in the grand scheme of things, it is still a bit surprising, since the pharmaceutical giant is one of the undisputed leaders in the exciting market for weight loss drugs.It turns ou...The Motley Fool
Sun, Feb 2
Meta Platforms' Revenue Jumps as It Plans to Invest Big in AI. Is the Stock a Buy?
Meta Platforms' (NASDAQ: META) share price rose after the social media company released strong fourth-quarter results, once again showing that its social media sites are top destinations for both users and advertisers. The company also remained committed to spending big on artificial intelligence (A...The Motley Fool
Sun, Feb 2
1 Glorious Reason Warren Buffett Would Appreciate Netflix Stock
Netflix (NASDAQ: NFLX) continues to be a winning bet for investors. Shares are up 70% just in the past 12 months. And they have soared 1,420% in the past decade, crushing the performance of the S&P 500.Warren Buffett, the legendary investor who is the longtime CEO of Berkshire Hathaway, is familiar ...The Motley Fool
Sun, Feb 2
If You'd Invested $5,000 in Innovative Industrial Properties Stock in 2018, Here's How Much You'd Have Today
Innovative Industrial Properties (NYSE: IIPR) is a standout among marijuana stocks. Unlike a great many other publicly traded companies in the weed industry, the cannabis-focused real estate investment trust's (REIT) shares have actually appreciated in price over the years. In fact, they've grown co...The Motley Fool
Sun, Feb 2
With New Glenn Rocket a Success, Blue Origin's Next Step Is to Build a $100 Billion Orbital Reef
The International Space Station (ISS) has given America a home in space for the last 27 years. Sometime after 2030, though, America plans to lock the doors on ISS, hand in the keys, and send it plunging into the sea. But this won't be the end of America's orbital adventures. Long before ISS takes it...The Motley Fool
Sun, Feb 2
ExxonMobil Dominated Last Year, Delivering 1 of Its Best Performances of the Past 10 Years
ExxonMobil (NYSE: XOM) is a powerhouse in the oil patch. The oil giant delivered an industry-leading financial performance last year, producing over $33 billion in earnings and $55 billion in cash flow from operations. That was its third-best performance over the past decade.What's remarkable about ...The Motley Fool
Sun, Feb 2
3 Tech and AI Stocks That Just Blew the Cover Off of Earnings
With earnings season now in full swing, investors and analysts are carefully monitoring the results, particularly on high-flying tech and artificial intelligence stocks trading at rich valuations and after the emergence of DeepSeek, which rocked the sector.Most publicly traded companies report their...The Motley Fool
Sun, Feb 2
3 Reasons Why Warren Buffett Should Buy Chipotle Stock Hand Over Fist, and 1 Reason Why He Might Regret It
Warren Buffett is certainly familiar with the restaurant industry. Berkshire Hathaway, the conglomerate he has been running for decades, owns Dairy Queen. And it has previously owned Restaurant Brands International.I think the Oracle of Omaha likes the durability of these businesses. After all, peop...The Motley Fool
Sun, Feb 2
Prediction: 3 Stocks That'll Be Worth More Than Amazon 10 Years From Now
It comes as no surprise to most investors that with a market cap of $2.5 trillion, Amazon (NASDAQ: AMZN) is one of the stock market's biggest companies. And deservedly so. It's grown into the e-commerce giant it is today by becoming the United States' premier online shopping platform. It's also the ...The Motley Fool
Sun, Feb 2
Is SoFi Stock a Buy Now?
SoFi Technologies (NASDAQ: SOFI) recently reported its earnings results, which looked quite stellar. The company beat earnings estimates laid out by analysts, and posted its first full-year GAAP profit since going public in 2021.The company did a good job growing its capital-light businesses, which ...The Motley Fool
Sun, Feb 2
Could This Be the Catalyst That Sends Bitcoin Up to $200,000 This Year?
Bitcoin (CRYPTO: BTC) has been on an incredible run over the past six months, rising by 50% in value and hitting a massive milestone along the way, as it topped $100,000 for the first time ever. Crypto investors have been bullish on the recent election results, hopeful that President Donald Trump wi...The Motley Fool
Sun, Feb 2
3 Reasons to Buy Amazon Stock Like There's No Tomorrow
There are many high-flying stocks out there right now benefiting from enormous trends. But it can be difficult to gauge whether they're just flash-in-the-pan companies or great long-term investments.Thankfully, plenty of established companies offer investors an opportunity to benefit from emerging t...The Motley Fool
Sun, Feb 2
Better Dividend Stock: Realty Income vs. AT&T
Realty Income (NYSE: O) and AT&T (NYSE: T) are both popular stocks for income-oriented dividend investors. Realty is one of the world's largest real estate investment trusts (REITs), and AT&T is one of the top telecom companies in America.The stock for both Realty and AT&T slumped in 2023 as rising ...The Motley Fool
Sun, Feb 2
This Weight Loss Stock Could Soar Over 220%, According to Wall Street. Time to Buy?
Medications known as glucagon-like peptide 1 (GLP-1) receptor agonists are taking over the healthcare industry. While you may not be familiar with the term "GLP-1," I'd wager you'll recognize some of the most popular ones on the market today, including Ozempic, Wegovy, Mounjaro, and Zepbound. Each o...The Motley Fool
Sun, Feb 2
